- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2040-2384
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting lymphatic vessel functions through tyrosine kinases ; volume:2 ; number:1 ; day:11 ; month:8 ; year:2010 ; pages:1-13 ; date:12.2010
Journal of angiogenesis research ; 2, Heft 1 (11.8.2010), 1-13, 12.2010
- Urheber
-
Williams, Steven P.
Karnezis, Tara
Achen, Marc G.
Stacker, Steven A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/2040-2384-2-13
- URN
-
urn:nbn:de:101:1-2021082907441590243508
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Williams, Steven P.
- Karnezis, Tara
- Achen, Marc G.
- Stacker, Steven A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Tyrosine kinases in rheumatoid arthritis
Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products
Platelet extracellular vesicles preserve lymphatic endothelial cell integrity and enhance lymphatic vessel function
Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
Development of novel bispecific antibodies for cancer therapy targeting the receptor tyrosine kinases HER4 and EGFR
Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
Lymphatic vessel density and function in experimental bladder cancer
Neurotrophin receptor tyrosine kinases regulated with near-infrared light
Percutaneous afferent lymphatic vessel sclerotherapy for postoperative lymphatic leakage after previous ineffective therapeutic transpedal lymphangiography
Editorial: Targeting bruton tyrosine kinase
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Tyrosine kinases in rheumatoid arthritis
Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products
Platelet extracellular vesicles preserve lymphatic endothelial cell integrity and enhance lymphatic vessel function
Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
Development of novel bispecific antibodies for cancer therapy targeting the receptor tyrosine kinases HER4 and EGFR
Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
Lymphatic vessel density and function in experimental bladder cancer
Neurotrophin receptor tyrosine kinases regulated with near-infrared light
Percutaneous afferent lymphatic vessel sclerotherapy for postoperative lymphatic leakage after previous ineffective therapeutic transpedal lymphangiography
Editorial: Targeting bruton tyrosine kinase
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Tyrosine kinases in rheumatoid arthritis
Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products
Platelet extracellular vesicles preserve lymphatic endothelial cell integrity and enhance lymphatic vessel function
Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
Development of novel bispecific antibodies for cancer therapy targeting the receptor tyrosine kinases HER4 and EGFR
Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
Lymphatic vessel density and function in experimental bladder cancer
Neurotrophin receptor tyrosine kinases regulated with near-infrared light
Percutaneous afferent lymphatic vessel sclerotherapy for postoperative lymphatic leakage after previous ineffective therapeutic transpedal lymphangiography